stella
beta
A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma — Stella
Home
/
Recurrent Glioblastoma
/
View on ClinicalTrials.gov
Recruiting
Back to Recurrent Glioblastoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
Belgium
UZ Brussel, Brussels